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Post-ischemic acute renal failure protects proximal tubules
from 02 deprivation injury, possibly by inducing uremia
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Post-Isehemic acute renal failure protects proximal tubules from 02
deprivation injury, possibly by Inducing uremia. Rats within the early
maintenance phase of post-ischemic acute renal failure (ARF) can resist
additional ischemic insults. This study assessed whether this protection
exists directly at the tubular cell level, and if so, whether it is a
consequence of prior cell injury (for example, due to heat-shock protein
synthesis; HSP), or if it arises in response to reductions in functional
renal mass and/or the uremic environment. Rats were subjected to
either 15 or 35 minutes of unilateral or bilateral renal ischemia, and after
15 minutes to 24 hours of reflow, proximal tubular segments (PTS) were
isolated for study. Their viability following oxygenation and hypoxic/
reoxygenation injury (HIR) was tested (LDH release). The influence of
uremia/reduced renal mass was determined by studying PTS extracted
24 hours after l'/2 nephrectomy, and by determining whether PTS
exposure to a "uremic milieu" (urine addition) blocks HIR damage.
HSP effects were gauged by correlating renal cortical HSP-70 expres-
sion with degrees of in vitro protection, and by ascertaining whether in
vivo hyperthermia (42°C; 15 mm) mitigates subsequent PTS H/R dam-
age. Results were compared with those obtained from normal PTS. The
in vivo experimental protocols did not substantially alter PTS isolation
or their viability during oxygenation. Fifteen minutes of ischemia
induced neither azotemia nor PTS cytoprotection. In contrast, 35
minutes of ischemia conferred marked protection against subsequent
H/R, but only when azotemia was permitted to develop (protection seen
after 24 hr, but not at 4 hr of reflow; protection abrogated by retention
of I normal kidney). Renal failure in the absence of tubular necrosis (1'/z
uninephrectomy) protected PTS from H/R damage. Adding urine di-
rectly to PTS also lessened HIR injury, independent of pH or osmotic
effects. Post-ischemic HSP synthesis correlated poorly with cytoresis-
tance, and hyperthermia-induced HSP expression exerted only a trivial
protective effect. These results indicate that: (a) post-ischemic ARF
directly protects tubular cells against subsequent 02 deprivation injury;
and (b) this appears to result not from cell injury per Se, but rather, by
exposure to a uremic environment.
In 1984, this laboratory made the novel observation that rats
which are at the height of post-ischemic acute renal failure
(ARF) are relatively resistant to subsequent ischemic insults
[1]. This was demonstrated by inducing ARF with 40 minutes of
bilateral renal ischemia, and then 18 to 48 hours later, at the
height of azotemia, re-challenging them with a second ischemic
event. The loss of renal function and morphologic damage
which resulted from this second ischemic insult (25 or 40 mm)
was markedly less than that which occurred in control rats
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which had not experienced prior renal ischemia. Injecting
normal rats with urine, thereby rendering them "uremic," also
made them resistant to superimposed ischemic injury. Thus, we
hypothesized that the protection observed in the post-ischemic
kidney was probably not a result of prior cell injury per Se, but
rather, it arose in response to solute/volume loading or from
exposure to the uremic environment. Further support for this
hypothesis was obtained in a subsequent study in which normal
rats, subjected to progressive surgical ablation of renal mass,
and hence, to increasing degrees of azotemia, demonstrated
increasing degrees of protection against subsequent ischemic
damage [2]. That a third study found that 15 minutes of renal
ischemia, which caused no azotemia, induced no protection,
supported this view [3].
Because each of the above studies relied only on in vivo data,
it could not be determined whether the post-ischemic kidney
manifests direct tubular cell resistance to subsequent ischemic
injury, or whether the protection is indirect, such as being
mediated by renal failure-induced intravascular volume expan-
sion, solute loading, or some other systemic effect. That both
volume expansion and solute loading can each mitigate post-
ischemic tubular necrosis and ARF [4—6] implies that a direct
change in cellular resistance might not be a prerequisite for
renal protection to develop. Nevertheless, in recent years it has
become increasingly apparent that proximal tubular injury can
lead to adaptive cellular changes which may directly mitigate
subsequent ischemic/hypoxic damage. For example, a number
of disparate toxins, such as gentamicin [7], inorganic iron [8],
and phospholipase A2 [9], can each protect isolated rat proximal
tubular segments (PTS) from hypoxic injury. Recently, it has
been demonstrated that administration of small doses of Na
azide, a mitochondrial respiratory chain inhibitor, can attenuate
in vivo post-ischemic ARF [10]. That various forms of cell
injury elicit the rapid synthesis of cytoprotectant proteins (the
"heat shock" response; [11—17]) provides at least one rational
explanation for these observations, while offering an alternative
hypothesis to uremic solute loading/volume expansion as the
reason for the post-ischemic kidney's resistance to subsequent
ischemic insults.
Given these uncertainties, the goal of the current study was
to resolve whether post-ischemic ARF directly protects proxi-
mal tubular cells against subsequent 02 deprivation injury. To
this end, proximal tubules, the prime target of ischemic renal
injury, were isolated from normal and post-ischemic kidneys,
and then their vulnerability to 02 deprivation injury was tested.
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By using this in vitro system, it was possible to remove con-
founding intraluminal [18] and hemodynamic [18—22] changes
which are inherent to in vivo ARF, thereby permitting direct
assessments of cellular resistance to hypoxic damage. In addi-
tion, the influence of (a) in vivo solute loading, (b) reductions in
renal mass, (c) exposure to an in vitro uremic environment, and
(d) HSP synthesis on tubular cell resistance, could be directly
tested.
Methods
Induction of in vivo ische,nic injury
Male Sprague-Dawley rats (175 to 250 g; Charles River
Laboratories, Wilmington, Massachusetts, USA), maintained
under standard vivarium conditions, were anesthetized with
pentobarbital (40 mg/kg), a midline abdominal incision was
made, and then bilateral renal pedicle occlusion (RPO) was
induced for either 15 or 35 minutes with smooth vascular
clamps while maintaining a 37°C body temperature. The 15-
minute clamp time was chosen because it induces ischemic
damage to proximal tubules (for example, brush border bleb-
bing; profound ATP depletion), while avoiding tubular necrosis
and filtration failure [31. The 35-minute clamp time was selected
because it induces severe filtration failure, but the resultant
tubular necrosis is almost totally confined to the outer medul-
lary stripe [23], making it possible to obtain a normal number of
intact tubules from the renal cortex for subsequent study (see
below). Rats subjected to 15 minutes of RPO had their kidneys
resected after either 15 minutes (N = 3), 1 hour (N = 5), 2 hours
(N = 3), 4 hours (N = 4), or 24 hours (N = 4) of reflow. The rats
which underwent 35 minutes of bilateral RPO had their kidneys
removed after either 4 hours (N = 4) or 24 hours (N = 6) of
reflow. Controls consisted of surgically paired rats subjected to
renal pedicle localization, but not occlusion. All rats that
completed a 24-hour reflow period (during which time free
food/water were provided) had blood urea nitrogen (BUN)
determinations at the time of kidney resection as an index of
filtration failure.
Isolation of proximal tubular segments from post-ischemic
and control kidneys
At the appropriate reperfusion time, the post-ischemic rats,
and their time-matched surgical controls were re-anesthetized
and both sets of kidneys were excised and immediately placed
in an ice cold buffer (primary buffer), consisting of (in mmoll
liter): NaCI, 100; KCI, 2.1; Na}1C03, 25; KH2PO4, 2.4; MgSO4,
1.2; MgCl2, 1.2; CaCI2, 1.2; glucose, 5; alanine, 1; Nalactate, 4;
dextran, 0.6%; gassed with 95% 02-5% CO2 (pH 7.4). The
cortical regions were dissected on a cool surface, finely minced
with a razor blade, and then subjected to 30 minutes of
collagenase digestion (collagenase D, Boehringer-Mannheim,
Indianapolis, Indiana, USA; 1.5 mg/mI) in S ml of the primary
buffer to which was added 2.5 mg/ml fatty acid free bovine
serum albumin (final pH adjusted to 6.5 with HC1 addition). The
digestions were conducted in siliconized 50 ml Erlenmeyer
flasks at 36°C in a shaking water bath, the reaction being
stopped by the addition of 10 ml of iced buffer. The digested
tissues were passed through a stainless steel sieve and centri-
fuged. The pellet was washed with 30 ml of iced buffer, and
after centrifugation, it was added to 15 ml of 31% Percoll (made
up in the primary buffer, NaC1 being added to maintain the
original buffer osmolarity). It was centrifuged at 3,000 rpm at
4°C for 10 minutes, the viable PTS being recovered at the
bottom of the tube, as previously described [8, 9]. The pelleted
PTS were washed twice as noted above to remove the Percoll
and then the PTS were suspended (--3 to 6 mg proteinlml) in an
experimentation buffer identical to the primary buffer, except
for 10 mmollliter Na butyrate addition. The PTS were re-gassed
with 95%02-5%C02, rewarmed from 4°C (isolation tempera-
ture) to 36°C (experimentation temperature) over 15 minutes in
a shaking water bath, and then a baseline % lactate dehydro-
genase (LDH) release (% of total suspension LDH in the buffer)
was determined as an index of PTS viability [8, 9]. Finally, the
PTS suspension was divided into a sufficient number of 2.5 ml
aliquots (in 25 ml Erlenmeyer flasks) to permit the experiments
described below. [Note: the P1'S yield from control and post-
ischemic kidneys were both quantitatively and qualitatively
similar was ascertained by (a) visually documenting that the
amount of pelleted material at the end of the isolation protocol
was the same for the two groups; (b) documenting that the total
amount of LDH recovered (an index of tubular recovery; [24])
was also comparable; and (c) by demonstrating that the mor-
phologic appearance of recovered tubules was the same for
control and post-ischemic kidneys, with —90% of the material
having a proximal tubular appearance. Indeed, since 15 minutes
of ischemia induces no tubular necrosis [3], and 35 minutes of
ischemia only induces necrosis in outer medullary stripe [23],
the finding of comparable PTS recovery from the control and
post-ischemic tissues was not unexpected].
PTS experimentation
Each of the above experimental P1'S preparations, and their
surgically matched controls, were each divided into three equal
aliquots: (1) continuous oxygenation; the flask was reoxygen-
ated (95% 02-5% C02), and then subjected to 45 minutes of
incubation in a 36°C shaking water bath; (2) mild hypoxic
injury; this flask was gassed with 95% N2-5% CO2 and incu-
bated for 15 minutes, followed by a 30-minute reoxygenation
period; (3) severe hypoxic injury; this flask was treated as per
flask #2, except that 30 minutes of hypoxia and 15 minutes of
reoxygenation were performed. At the completion of the above
incubations (each 45 mm in length), cellular injury was assessed
by re-determining the % LDH released. In each experiment, the
post-ischemic PTS and their time matched controls were stud-
ied simultaneously.
Unilateral in vivo ischemia experiments
The above experiments indicated that 35 minutes, not 15
minutes, of bilateral renal ischemia conferred protection against
subsequent hypoxic tubular injury (Results). This experiment
assessed whether that protection was a direct consequence of
the tubular injury or whether it was dependent on the renal
failure which resulted. To this end, seven rats were subjected to
35 minutes of left renal vascular occlusion. The right kidney
was left uninjured, thereby preventing the development of
severe renal failure. After a 24-hour recovery period, the BUN
was determined and the post-ischemic kidneys were resected
and used for PTS isolation. One kidney from a sham operated
rat provided control PTS. Each preparation was divided into
two aliquots: (1) continuous oxygenation; and (2) the 30 minute
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hypoxia/iS minute reoxygenation protocol. The % LDH release
was determined at the completion of the 45 minute incubations.
Renal ablation: Effects on PTS susceptibility to subsequent
hypoxic injury
This set of experiments was designed to assess whether
severe reductions in renal mass, induced in the absence of
ischemic tubular necrosis, protect residual nephrons from sub-
sequent hypoxic injury. Rats were subjected to left unilateral
nephrectomy plus a right hemi-nephrectomy, the latter created
by electrocautery resection of the upper pole, (performed over
30 to 45 seconds during which time the renal artery was
occluded to maintain hemostasis). The rats were then sutured
and allowed to recover from anesthesia, free food and water
access being provided. Twenty-four hours later, BUNs were
determined and then the residual renal tissues were resected
and used for PTS isolation. A comparable amount of tissue
obtained from sham operated rats provided control PTS. To
confirm that the residual tissue was morphologically normal, a
remnant kidney obtained from this protocol was fixed in methyl
Carnoy's and 5 micron sections, stained with hematoxylin and
eosin, were examined.
To ascertain whether prevention of azotemia in the above
protocol would mitigate the protection found, additional rats
were subjected to right hemi-nephrectomy, leaving the left
kidney in place. PTS were then isolated from the residual right
kidney and subjected to the above protocol (N = 4 paired
assessments).
Assessment of whether normal urine contains a proximal
tubular cytoprotectant
Since each of the above experiments suggested that uremia
confers protection against subsequent hypoxic tubular damage,
the following experiment tested whether creation of an in vitro
"uremic environment" might directly protect PTS from injury.
To achieve this goal, the effects of normal human urine (NHU)
addition on PTS susceptibility to hypoxic injury was assessed.
To this end, eight separate PTS preparations, obtained from
normal rats, were each divided into four aliquots as follows:
(1,2) continuous oxygenation x 45 minutes in the presence or
absence of a NHU sample (see below); or (3,4) hypoxia!
reoxygenation (30/15 mm) in the presence or absence of NHU.
Eight different first-morning urine samples, obtained from five
healthy individuals, were each tested (after pH correction to 7.4
with NaOH). A 300 d sample was added to 2.2 ml of the PTS
suspension. The nonurine exposed aliquots had 300 .d of PTS
buffer added to maintain a constant incubation volume. At the
completion of the 45 minute incubations, % LDH release was
assessed. The urine samples contained no measurable LDH and
the urine did not interfere with assay performance.
To determine whether the results obtained in the above
experiments were due to a urine induced increment in osmolal-
ity, or from a well defined urinary constituent, an "artificial"
(simulated) urine was created with the following characteristics:
(in g/liter): NaCI 7.3; urea 29; KCI 3.0; NaH2PO4 2.1; CaCI2 2
H20 2.0; uric acid 0.5; creatinine 1.6; NH4C1 2.1; Na citrate 0.5;
oxalate 0.04; pH 7.4; osmolality 900 mOsm/liter. These concen-
trations were chosen to reproduce exactly those found in one of
the above, and representative, normal urine samples. The effect
of this simulated urine was assessed in three PTS preparations,
each divided into four aliquots as follows: (1,2) continuous
oxygenation with either simulated urine or NHU addition, and
(3,4) hypoxia!reoxygenation (30/15 mm) with simulated urine or
NHU addition. The % LDH release was then determined.
Intravascular volume expansion experiments
The following experiment assessed whether intravascular
volume expansion/solute loading, such as occurs in ARF, might
protect PTS from subsequent hypoxic damage. Two methods of
volume/solute loading were used: (1) rats (N = 3) were lightly
anesthetized and injected intraperitoneally with 30 ml of 0.9%
NaCI, to which was added 8 g/liter urea. This same solution
replaced their drinking water, and 24 hours later PTS were
isolated for study; and (2) rats (N = 3) were anesthetized, a
jugular venous catheter was placed, and then they were infused
with 20 ml of 0.9% NaCI over two hours. At the completion of
these protocols (24 hrs, 2 hrs), PTS were harvested and they
were subjected to the oxygenation and the 15 and 30 minute
hypoxia!reoxygenation protocols as previously described.
Sham treated rats were used for controls.
Hyperthermic heat shock: Effects on PTS' susceptibility to
hypoxic injury
Since heat-shock protein (HSP) synthesis occurs in the
aftermath of ischemic injury (see below), and because these
proteins can exert cytoprotective effects, the following experi-
ment assessed whether hyperthermia-triggered HSP mitigates
hypoxic PTS injury. Thus, this protocol permitted an assess-
ment of HSP effects in the absence of ischemic damage. Rats
were subjected to 15 minutes of 42°C hyperthermia by placing
them under heating lamps while under light pentobarbital
anesthesia with continuous rectal temperature monitoring. Af-
ter a 24-hour recovery period, PTS were harvested and sub-
jected to either continuous oxygenation (45 mm) or to the 30
minute hypoxia/15 minute reoxygenation protocol. The results
were compared to those obtained from sham treated controls (N
= 5 per group).
Assessment of heat-shock protein synthesis
To gauge HSP production in response to the above protocols,
the generation of HSP-70, a dominant and ubiquitous member
of the HSP family, was assessed. To this end, rat renal cortices,
obtained from each of the above experiments, were isolated and
suspended in 2 volumes (wt!wt) of TBS (Tris-buffered saline;
0.15 M NaC1, 10 ms Tris-HC1, pH 7.4, 0.02% thimerosal)
containing S mI/liter of a protease inhibitor cocktail (0.1 mg/mI
iodoacetamide, 6.3 d/ml of diisopropylfluorophosphate, 2
mg/ml of pepstatin, chymostatin, and leupeptin in dimethyl
sulfoxide) and homogenized on ice with a Polytron tissue
dispenser. The homogenates were centrifuged at 14,000 g for 30
minutes at 4°C, using a Beckman J2-21 centrifuge with a JA-18
rotor. The supernatants were saved for subsequent analysis. All
SDS-polyacrylamide gel electrophoreses were performed under
reducing conditions by the method of Laemmli [25]. Precasted
gels were used with a linear gradient of 4 to 20% acrylamide
(Bio-Rad, Richmond, California, USA). Samples were dena-
tured by boiling for three minutes in the presence of 2% SDS
and 2% /3-mercaptoethanol. Electrophoresis was conducted at
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Table 1. Percent LDH released from control PTS and from PTS harvested from rats subjected to 15 minutes of bilateral ischemia and variable
lengths of reflow
N
Baseline Oxygenation
15-mm
hypoxia
30-mm
hypoxia Total
LDH%
15-mm reflow 3 5 1 12 1 23 1 49 5 1792 112
Control 3 4 1 14 3 25 0 48 4 1536 160
1-hr reflow 5 7 1 12 2 22 2 40 5 1648 160
Control 5 7 1 13 1 24 2 46 2 1648 96
2-hr reflow 3 7 1 14 1 26 3 50 5 1600 256
Control 3 7 1 12 3 28 3 52 2 1424 224
4-hr reflow 4 8 1 16 2 31 1 54 1 1200 64
Control 4 8 1 13 1 29 2 51 3 1424 128
24-hr reflow 4 8 1 14 1 29 5 46 6 1456 112
Control 4 8 1 15 1 28 4 49 3 1568 184
Baseline values are % LDH released at start of experiments. Oxygenation is % LDH release after 45 minutes incubation under 95% 02-5% C02;
15 minute hypoxia is % LDH released after 15 minutes of hypoxia plus 30 minutes of reoxygenation; 30 minutes hypoxia is % LDH released after
30 minutes hypoxia plus 15 minutes reoxygenation. Total LDH is LDH units/mi of the final PTS suspension, a reflection of the number of PTS
isolated [24]. No statistical differences were observed in any of the above comparisons.
200 volts for 40 minutes. Proteins in the gels were blotted onto
a nitrocellulose membrane using Bio-Rad's electroblotting ap-
paratus. Immunoblots of these gels were sequentially probed
with primary antibody against human HSP-70 (Amersham,
Arlington Heights, Illinois, USA), and then with horseradish
peroxidase (HRP)-labeled secondary antibodies against mouse
immunoglobulin. Five percent non-fat dry milk was used as a
blocking reagent. Bound HRP activity was detected by an
enhanced chemiluminescence method (ECL kit; Amersham).
Molecular weight estimates from SDS-PAGE were made using
the following standards: rainbow markers (Amersham; myosin
200 kDa), phosphorylase b (92.5 kDa), bovine serum albumin
(69 kDa), ovalbumin (46 kDa), carbonic anhydrase (30 kDa),
trypsin inhibitor (21.5 kDa), and lysozyme (14.5 kDa). The
following samples (N = 2 to 4 per treatment) were tested:
normal kidneys; kidneys 4 hours and 24 hours after 15 or 35
minutes of bilateral renal ischemia; kidneys 24 hours after 35
minutes of unilateral renal ischemia; kidneys 24 hours after
hyperthermia; and remnant tissues following electrocautery
hemi-nephrectomy.
Calculations and statistics
All values are presented as means 1 SEM. Statistical
comparisons were performed by paired Student's t-test, unless
stated otherwise. Statistical significance was judged by a P
value of < 0.05.
Results
15-Minute bilateral RPO experiments
The results of experiments conducted on PTS extracted from
kidneys subjected to 15 minutes of bilateral ischemia plus
variable reflow periods are presented in Table 1. No difference
in their viability was noted, compared to the control PTS,
whether assessed at baseline, following 45 minutes of continu-
ous oxygenation, or in the aftermath of the hypoxia-reoxygen-
ation protocols. As discussed previously, prior in vivo ischemia
did not alter Fl'S yields (such as documented by the LDH
recovery data; Table 1). The 15-minute bilateral ischemia
protocol caused no azotemia, as assessed by the 24 hour BUN
concentrations (post-ischemia, 14 1 mg/dl; sham operated
controls, 14 1 mgldl).
35-Minute bilateral RPO experiments
Figure 1 depicts % LDH releases from control PTS and from
PTS which were harvested from rats which were either 4 hours
(Fig. lA) or 24 hours (Fig. 1B) after 35 minutes of bilateral renal
ischemia. The degree of PTS viability was comparable for the
post-ischemic PTS and their time matched controls, both at
baseline and after 45 minutes of oxygenation (Fig. 1) and as
previously stated, prior in vivo ischemia did not significantly
compromise P1'S recovery from the kidneys (such as the total
LDH concentrations not significantly differing from those of the
controls preparations; values comparable to those given in
Table 1).
The 4-hour post-ischemic PTS demonstrated only a very
slight (—2 to 4%) decrease in the severity of hypoxic injury,
compared to the control PTS (Fig. 1A). In contrast, the 24-hour
post-ischemic PTS were markedly protected against hypoxic
damage, with an approximate 2/3 second reduction in hypoxia-
induced cell death (Fig. 1B). In addition, the 24-hour post-
ischemic PTS showed slightly better viability than the control
PTS both at baseline and after 45 minutes of oxygenation (Fig.
1B). The BUN at 24 hour post-bilateral 35 minute RPO was 113
17 mg/dl.
35-Minute unilateral ischemia experiments
The presence of one normal kidney markedly attenuated the
cytoprotection which was produced by 35 minute ischemia plus
24 hr of reflow: whereas the PTS harvested in the aftermath of
bilateral 35 minute ischemia + 24 hours of reflow had a
reduction in % LDH release from 52% to 24% ( of 28 4%;
Fig. lB), the unilateral 35 minute ischemia + 24 hour reflow
protocol only reduced LDH release from 48 2% to 39 2%;
9 2%; data not shown). These decrements (28% vs. 9%)
were highly statistically different (P < 0.001; unpaired t-test).
Thus, the presence of a normal contralateral kidney marked
attenuated the cytoprotection afforded by prior in vivo ischemic
injury (presumably by attenuating the development of renal
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failure). The 24 hour BUNs for these rats were 19 1 and 15
1 mg/dl; unilateral ischemia, controls, respectively).
Renal ablation experiments
The 1 V2 nephrectomy protocol induced marked azotemia (ill
14 mg/dl), and as depicted in Figure 2, the PTS extracted
from these remnant kidneys were markedly protected against
hypoxic-reoxygenation injury, with an approximate 2/3 reduc-
tion in hypoxia-triggered LDH release resulting (P < 0.001). In
addition, these PTS also manifested slightly lower LDH re-
lease, both at baseline and after 45 minutes of continuous
oxygenation. In contrast, if only a '/2 nephrectomy was under-
taken, the PTS extracted from the post-ablated kidney demon-
strated no significant protection against hypoxic damage (con-
trols, 63 5% vs. post-ablation, 52 7%; NS; not depicted).
The % LDH released under oxygenated conditions for these /2
nephrectomy experiments also did not differ versus their con-
trols (17 1%; 17 3%). Thus, these results indicate that the
cautery resection procedure per se was not responsible for the
protection noted in the 1 '/2 nephrectomy experiments. Of note,
this same 1 V2 nephrectomy protocol has previously been re-
ported to protect against in vivo ischemic damage [2].
Effects of urine and simulated urine addition on PTS viability
Fig. 1. The % LDH release during continuous
oxygenation and in response to the mild and
severe hypoxic challenges. H/R = hypoxia!
reoxygenation, the length of each being given
immediately below. Symbols are: (0) normal;
() post-RPO. (A) Results with control PTS
and PTS obtained 4 hours after 35 minutes of
bilateral renal pedicle occlusion (RPO). A
quantitatively trivial (but statistically
significant), decrease in % LDH release was
observed in the post-ischemic PTS in
response to the 30 minute, but not the 15
minute hypoxic challenge (overall analysis, P
<0.04). (B) Results obtained with control
PTS and P'FS obtained 24 hours after 35
minutes of bilateral RPO. The post-ischemic
PTS were markedly protected against both the
15 minute and 30 minute hypoxic insults, with
approximately 2/3 of the hypoxia-induced
LDH increment being prevented.
Neither urine nor the simulated urine addition influenced PTS
viability (LDH release) under oxygenated conditions. How-
ever, urine markedly decreased PTS hypoxic/reoxygenation
injury (Fig. 3A), a result which was not reproduced by the
simulated urine addition (Fig. 3B). Thus, the urine contained a
cytoprotectant which was not present in the "simulated urine."
Volume expansion experiments
Neither of the two volume expansion protocols altered sub-
sequent PTS viability during oxygenation or in response to
hypoxia/reoxygenation injury and, for the sake of brevity, the
LDH release results for these two protocols are presented
together (volume expanded/controls, respectively): 45 minutes
of oxygenation, 15 l%/14 1%; 15 minutes of hypoxia-30
minutes of reoxygenation, 37 3%/40 5%; 30 minutes of
Fig. 2. The % LDH released from normal PTS (0) and FTS extracted
from remnant tissues following 1½ nephrectomy (s). The latter re-
vealed slightly better viability than the control PTS at baseline and
during oxygenated incubation, and they were markedly protected
against hypoxic-reoxygenation injury. In contrast, PTS extracted from
heminephrectomized kidneys (with the contralateral kidney in place)
demonstrated no protection against hypoxic damage (not depicted).
hypoxia-15 minutes of reoxygenation, 56 2%/56 4%
(all NS).
HSP effects independent of renal ischemia
As depicted in Figure 4, hyperthemia conferred significant
protection against 30 minutes of hypoxic/reoxygenation injury,
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Fig. 3. The % LDH released from normal
PTS which were subjected to conhinuous
oxygenation or 30 minutes of
hypoxia/reoxygenation (HIR) in the presence
or absence of normal human urine. Symbols
are: (0) controls; (•) normal urine; ()
simulated urine. The urine markedly
diminished hypoxic injury without altering
PTS viability under oxygenated conditions
(A). This protective effect was not reproduced
by the simulated urine addition (B), indicating
that it was not due to hyperosmolality, urea,
NaCI, or to any of the other normal urinary
constituents tested.
Base- 45 mm
line 02
but it was very modest, only decreasing % LDH release from 61
2% to 53 3% (P < 0.005). As discussed below, this
hyperthermic protocol induced a massive HSP-70 response.
HSP synthesis in response to the experimental protocols
No HSP-70 was observed in either the normal kidneys or the
kidneys extracted 4 hours or 24 hours following 15 minutes of
bilateral ischemia. In contrast, definite, and comparable,
HSP-70 expression was seen in each of the following samples
(Fig. SA): (a) the kidneys which were resected either 4 or 24
hours post-35 minutes of ischemia; (b) the kidneys which
underwent 35 minutes of unilateral ischemia (that is, the pres-
ence of a normal contralateral kidney did not alter HSP-70
synthesis); and (c) the residual pieces of kidney that remained
24 hours following surgical hemi-nephrectomy. The kidneys
examined 24 hours following hyperthermia had profound
HSP-70 expression, far greater than that seen in any of the other
kidney samples (Fig. SB).
Discussion
In 1989, Gaudio et at demonstrated that it is possible to
isolate intact proximal tubules from post-ischemic rat kidneys,
thereby permitting the study of direct cellular responses to in
vivo tubular injury [26]. In the present study we used this same
approach to determine whether the resistance of the post-
ischemic kidney to subsequent damage is expressed directly at
the proximal tubular cell level, and if so, whether it is a result
of: (a) direct cellular adaptations to prior injury (such as
heat-shock protein synthesis), (b) stems from in vivo solute!
intravascular volume loading (well known consequences of
ARF); or (c) is a direct result of reductions in functional renal
mass and/or the resulting uremia. To achieve these goals, either
15 or 35 minutes of renal ischemia was induced in vivo, and after
variable reflow periods, PTS were harvested for study, the
results being contrasted to those obtained from simultaneously
isolated normal PTS. Of note, this experimental approach
theoretically could have been complicated by a tubular "selec-
tion artifact" created by an inability to isolate comparable PTS
populations from normal and post-ischemic kidneys. For exam-
ple, had the most hypoxia-sensitive tubules been lost during in
vivo ischemia or the subsequent isolation process, an appear-
ance of cytoresistance could have resulted. However, the
available information argues strongly against this possibility for
the following reasons: (1) at the completion of the PTS isolation
process, the amount of recovered (centrifuged/pelleted) mate-
rial visually appeared the same for the control and experimental
preparations (arguing against a disproportionate loss of PTS in
the post-ischemic groups); (2) the total amount of LDH within
the control and post-ischemic preparations (a direct reflection
of cell number; [24]) did not significantly differ; and (3) the
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Fig. 4. The % LDH released from normal PTS and PTS obtained from
rats subjected to 42°C hyperthermia 24 hours previously. Hyperther-
mia, imposed in vivo, conferred only a trivial protective effect despite
the induction of massive HSP-70 synthesis (see Fig. SB).
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Fig. 5. SDS-PAGE and western blot analysis of HSP-70 expression in renal cortex following the principal experimental protocols. A. Lane 1, 35
minutes RPO + 24hours reflow; Lane 2,35 minutes RPO + 4hours reflow; lane 3, 35 minutes of unilateral RPO + 24hours reflow; Lane 4, normal
kidney; Lane 5, 1 '/2 nephrectomy; Lane 6, normal kidney extracted 24 hours after a contralateral nephrectomy; Lanes 7,8, 15 minutes RPO + 24
hours and 4 hours reflow, respectively. B. Lane I, HSP-70 expression in renal cortex 24 hours after hyperthermia; and Lane 2, normal cortex. The
amount of HSP-70 expression was far greater in the post-hyperthermic tissues, vs. any of the post-ischemic tissue samples tested. The molecular
weight markers appear on the left with the arrows demonstrating the expected position of HSP-70.
microscopic appearance of the preparations revealed the same
degree of PTS enrichment (-90% of the total material present
being PTS). Indeed, that comparable PTS preparations could be
obtained from control and post-ischemic kidneys is not surpris-
ing since 15 minutes of in vivo ischemia causes no tubular
necrosis [3], and the necrosis which results from 35 minutes of
ischemia is virtually confined to the outer medullary stripe [24].
Since only cortical tissues were used for PTS isolation, "selec-
tion artifacts" were, thus, avoided. (Additional evidence
against a "selection artifact" as the basis for the results
obtained is presented during discussion of specific experiments
below).
Previous work from this laboratory has shown that 15 min-
utes of in vivo renal ischemia neither induces filtration failure,
nor substantially alters renal susceptibility to subsequent isch-
emic insults [3]. The present in vitro experiments support this
view since, irrespective of the length of reperfusion, 15 minutes
of in vivo ischemia caused no change in PTS vulnerability to
subsequent hypoxic damage. The lack of heightened vulnera-
bility to hypoxic injury in the 15 minute ischemiall5 minute
reperfusion group was somewhat surprising since 15 minutes of
reflow is insufficient time to repair the marked tubular ATP
depletion and plasma membrane damage which is triggered by a
15-minute ischemic insult [3]. Given these persistent defects,
one might have expected heightened vulnerability to hypoxic
damage to result. One possible reason why this did not occur is
that intracellular acidosis, a well known cytoprotectant [27],
may have persisted throughout 15 minutes of reflow, potentially
cancelling out a predilection to subsequent hypoxic damage. In
contrast to the above results, 35 minutes of bilateral ischemia
plus 24 hours of reflow conferred dramatic protection against
both the mild and severe hypoxic injury protocols, with approx-
imately 2/3 of LDH release being eliminated in both cases (Fig.
lB). Thus, these results indicate for the first time that the
protection which develops in the post-ischemic ARF kidney is
conferred directly at the proximal tubular cell level. Two
additional observations derived from these 35-minute ischemia
experiments are especially noteworthy. First, this protection
requires a substantial period of reperfusion to develop, since it
was highly expressed at 24 hours, but not at 4 hours, of reflow
(Fig. la); and second, the acquired resistance is largely elimi-
nated by the presence of a normal contralateral kidney. Thus,
these findings strongly suggest that it is not tubular injury per
se, butrather the resultant azotemialrenal failure which confers
the protective effect. This conclusion is based on the premise
that the retention of one normal kidney primarily mitigates
azotemia, not the extent of contralateral ischemic damage, and
that after 4 hours of reflow, substantial cell injury, but not
azotemia, exists. Thus, that severe bilateral injury plus 24 hours
of reflow are required for the emergence of marked cytoresis-
tance strongly suggests that azotemia/uremia plays a critical
role in its development. That the 15 minute ischemial24 hour
reflow protocol induced neither azotemia nor cytoprotection
further supports this view. One last important point emerges
from the above experiments is that 35 minutes of bilateral
ischemia conferred marked protection whereas 35 minutes of
unilateral ischemia did not, which seemingly excludes a "tubu-
lar selection artifact" as the explanation for the cytoresistence.
This is because the presence of one normal kidney cannot
reasonably be expected to alter PTS isolation from a contralat-
erally injured kidney.
In an effort to gain further support for the hypothesis that it is
renal failure and not ischemic tubular damage which is largely
responsible for the development of cytoresistance, renal failure
in the absence of cell necrosis was induced in rats using the 1 '/
nephrectomy protocol, and 24 hours later P1'S were isolated for
study. That both marked azotemia and cytoprotection resulted
strongly support the above hypothesis that renal failure!
azotemia, not cell injury, predominantly confers cytoresis-
tance. It is noteworthy that PTS extracted from hemi-nephrec-
tomized kidneys with the contralateral kidney in place were not
resistant to hypoxic damage. Thus, the surgical protocol per se
cannot be directly implicated in the emergence of protection. Of
note, this laboratory has previously shown that this same
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ablation model protects rats from in vivo ischemic ARF [2].
Thus, these new in vitro findings support our prior in vivo
observations, and demonstrate that the protection is conferred
directly at the cellular level. Lastly, these findings once again
underscore that a tubular "isolation artifact" is an unlikely
explanation for the cytoresistance noted in the aftermath of
ARF; since the residual nephrons within ablated kidneys are
essentially normal (confirmed by histology), PTS isolation
artifacts would not be expected.
Because each of the above experiments suggested that renal
failure, not tubular injury per se was responsible for the
development of cytoresistance, we next sought to determine
whether in vivo solute loading/intravascular volume expansion,
a consequence of severe ARF, might be responsible for the
protection which develops. To this end, rats were administered
saline urea and then PTS were isolated for study. However,
no protection against in vitro hypoxic injury was noted. As
previously discussed, acute volume expansion and solute load-
ing can each mitigate in vivo ischemic ARF [4—6], and the
present solute loading experiments do not refute those results.
Rather, they merely suggest that this previously documented in
vivo protection probably arises from hemodynamic or intralu-
minal effects.
Since a constant correlate of the cytoresistance noted in each
of the above experiments was the presence of azotemia, we
questioned whether some unknown substance, normally ex-
creted in urine, and hence retained in uremia, might confer
direct cytoprotection on tubules. To test this hypothesis, we
created an acute ex vivo "uremic milieu" by adding normal
human urine samples to PTS. To avoid pH effects on tubular
viability [27], all urine samples had their pH corrected to 7.4
prior to experimentation. As shown in Figure 3, the urine
additions conferred dramatic protection, approximately halving
hypoxic LDH release. Thus, these findings provide additional,
although indirect, support for the hypothesis developed above
that ARF-mediated protection is conferred not by cell injury per
se but rather by the renal failure which results. The identity of
the urinary cytoprotectant remains to be defined. At this time,
all that can be stated is that it is heat stable, it resists freezing,
it co-migrates with urea during size exclusion HPLC chroma-
tography (experiments not presented), and that it is not recre-
ated by hyperosmolality or any of the normal urinary constitu-
ents which were added to form the "simulated urine."
In recent years, there has been clear evidence presented that
in vivo renal ischemia can elaborate the 'heat shock protein"
response, as noted both by HSP elaboration [17, 28—30] and by
increased expression of HSP-70 mRNA [17, 30]. Since HSPs
are generally believed to be cytoprotective, it seemed logical to
hypothesize that HSP synthesis could have caused, or contrib-
uted to, the cytoresistance which we documented in post-
ischemic tubules. To test this hypothesis, renal cortical HSP-70
generation was assessed in response to each of the in vivo
protocols and, indeed, marked, and comparable, HSP elabora-
tion was observed 4 and 24 hours after 35 minutes of renal
ischemia, either in the presence or absence of a normal con-
tralateral kidney. Additionally, modest HSP synthesis was
observed in the '/2 and 1 '/2 nephrectomy experiments (undoubt-
edly due to heat exposure during the cautery procedure).
Nevertheless, we believe that HSP synthesis alone cannot
explain the bulk of protection noted in these experiments for the
following reasons: (1) that comparable HSP expression was
seen in response to 35 minutes of bilateral ischemial24 hours
reflow, 35 minutes ischemial4 hour reflow, and 35 minute of
unilateral ischemial24 hours reflow, and yet only the former
protocol induced dramatic protection, suggests that HSP syn-
thesis was either of secondary importance, or represents an
epiphenomenon; (2) that the '/2 nephrectomy and the 1½
nephrectomy protocols induced comparable HSP-70 produc-
tion, but that only the latter was associated with cytoprotection
further supports this view; and (3) that the most profound
HSP-70 expression observed, that induced by hyperthermia,
was associated with only a trivial protective effect (Fig. 4)
further suggests that HSP synthesis was not a prime factor in
the cytoresistance noted in the post-ablation/post-ischemia ex-
periments. That acute urine addition conferred immediate pro-
tection against hypoxic injury further supports this view since
this protocol allowed no time for a HSP synthetic response.
In conclusion, the present study provides the following new
insights: (1) in vivo ischemic renal injury confers dramatic and
direct cytoprotection upon proximal tubular cells against sub-
sequent hypoxic injury, suggesting that this is one reason why
the post-ischemic kidney may be relatively resistant to addi-
tional ischemic events; (2) concomitant, severe ARF is needed
for the full expression of this cytoprotection, since neither
bilateral sublethal ischemia (15 mm) nor severe unilateral isch-
emia (35 mm) substantially alters cellular resistance to subse-
quent hypoxic damage; (3) the protection conferred by ARF is
not dependent on the presence of severely damaged tubules
since PTS harvested in the aftermath of 1½ nephrectomy
demonstrate cytoresistance; (4) the creation of an in vitro
"uremic milieu" acutely protects PTS from hypoxic damage,
thereby supporting the hypothesis developed above: that ure-
mia, rather than tubular injury per se is primarily responsible
for the emergence of cytoresistance; and (5) induction of
HSP-70 in the absence of ischemia only slightly protects against
subsequent hypoxic damage. Thus, while HSP synthesis may
contribute to the development of cytoresistance, it is probably
not the dominant cause of it in post-ischemic tubules.
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